Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 32 of 281 for:    Genetic Diseases, Inborn AND Genome

Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02322177
Recruitment Status : Completed
First Posted : December 23, 2014
Last Update Posted : September 5, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Human Genome Research Institute (NHGRI) )

Brief Summary:

Background:

- People with inborn errors of metabolism can t turn food into energy the right way. This can affect a person s growth and health. Researchers want to know how this condition affects a pregnant woman and her baby.

Objectives:

- To collect data from the medical records of women with an inborn error of metabolism. Also, to create a pregnancy registry of inborn errors of metabolism.

Eligibility:

  • Women with an inborn error of metabolism who either:
  • have been pregnant in the past,
  • are currently pregnant, or
  • have recently talked with their doctor about becoming pregnant.

Design:

  • This study will collect data only. No extra tests will be done.
  • Participants will be in the study for the length of their pregnancy and for 1 year after delivery.
  • Participants will answer questions about their family s health.
  • The participant s doctor will send their medical records to researchers. These may include data about:
  • Last health care visit before pregnancy
  • Blood, urine, ultrasound, or lab results during pregnancy
  • Delivery and recovery after delivery
  • Researchers will ask for the test(s) used to confirm pregnancy.
  • After the participant has her baby, researchers will ask for data about how the baby is doing. This may include when the baby is sitting, walking, talking, etc.
  • The data will be placed into a database. The database will not include the participant s name or identifying data.

Condition or disease
Inborn Errors of Metabolism Pregnancy Acidemias

Detailed Description:

Women with inherited metabolic disorders are reaching child bearing age more often due to advances in early diagnosis and improved pediatric care. For many of these disorders, there is very little information in the literature to guide the counseling and treatment of these patients and their pregnancies.

The most information for the effects of an underlying inborn error of metabolism in pregnancy derives from the study of phenylketonuria (PKU). From the knowledge gained through the collection of information from multiple cases of pregnancy affected by PKU, important management issues were identified. For example, children born to mothers with an unrestricted diet were substantially more likely to have intellectual disability, microcephaly, and low birth weights than women who maintained a phenylalanine restricted diet. The excess phenylalanine poses long-term health risks to the developing fetus and now a vigilant metabolic approach is recognized as mandatory in women with PKU desiring pregnancy.

Compared to PKU, most or all other intermediary metabolic disorders have been understudied. For example, there are nine published cases of methylmalonic academia (MMA) in pregnancy and one case of cobalamin C deficiency in pregnancy, and review articles have reported the same cases. For other inborn errors of metabolism there is even less published or known. The paucity of publication of pregnancy in IEMs other than PKU may be due to the lack of organized research to address pregnancy management in metabolic disorders.

The objective of this study is to establish a pregnancy registry of women with inborn errors of metabolism other than PKU. We will collect management plans, baseline laboratory values, prenatal and postpartum course including metabolic and obstetrical issues, and fetal/neonatal outcomes. This study will also investigate reproductive issues including infertility and use of artificial reproductive technologies. A registry of this type will allow physicians and patients to report varying management and outcomes, both positive and negative, with the broader goal of delineating optimal maternal and fetal outcomes for these unique patient populations. Our registry data would also serve as a vehicle to disseminate management experience for all providers, recognizing that individual centers may not have sufficient experience to make accurate management decisions on their own.


Layout table for study information
Study Type : Observational
Actual Enrollment : 2 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Maternal Inborn Errors of Metabolism in Pregnancy: A Pregnancy Registry Protocol
Study Start Date : December 19, 2014
Actual Primary Completion Date : August 20, 2018
Actual Study Completion Date : August 20, 2018


Group/Cohort
1
Participants are women with inborn errors of metabolism who have been pregnant



Primary Outcome Measures :
  1. Maternal inborn errors of metabolism [ Time Frame: Yearly ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants are women with inborn errors of metabolism who have been pregnant
Criteria
  • INCLUSION CRITERIA:
  • Patients clinically diagnosed with methylmalonic acidemia or another inborn error of metabolism are eligible to participate; mutational and enzymatic status is preferred but not required. Biochemical testing is required.
  • Women with inborn errors of metabolism who have had a clinically documented prior pregnancy, currently are pregnant or planning a pregnancy.

EXCLUSION CRITERIA:

  • Patients with phenylketonuria or hyperphenylalaninemia.
  • Anyone unwilling to provide informed consent (for themselves as adults, or on behalf of their children as minors) or assent.
  • Medical condition(s) or mental retardation are not in themselves reason for exclusion if in the judgment of the referring physician this would involve no more than minimal risk. We will make every effort to explain the study for the purpose of assent in a manner that the family feels is both age and developmentally appropriate for that individual.
  • We will review a clinical description from the referring physician about a potential research subject to determine that the subject is appropriate to enter into the study. We reserve the right to exclude cases that are not definitively diagnosed by metabolites and/or molecular genetics or related to our direct research interests. We expect this to be a rare minority.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02322177


Locations
Layout table for location information
United States, Maryland
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, United States, 20892
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Human Genome Research Institute (NHGRI)
Investigators
Layout table for investigator information
Principal Investigator: Charles P Venditti, M.D. National Human Genome Research Institute (NHGRI)

Additional Information:
Publications:
Layout table for additonal information
Responsible Party: National Human Genome Research Institute (NHGRI)
ClinicalTrials.gov Identifier: NCT02322177     History of Changes
Other Study ID Numbers: 150049
15-HG-0049
First Posted: December 23, 2014    Key Record Dates
Last Update Posted: September 5, 2019
Last Verified: August 29, 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by National Institutes of Health Clinical Center (CC) ( National Human Genome Research Institute (NHGRI) ):
Inborn Error of Metabolism
Pregnancy
Amino acid disorder
Fatty acid oxidation disorder
Organic Acidemia
Additional relevant MeSH terms:
Layout table for MeSH terms
Metabolism, Inborn Errors
Acidosis
Genetic Diseases, Inborn
Metabolic Diseases
Acid-Base Imbalance